Real-Time Contrast-Enhanced-Guided Biopsy Compared with Conventional Ultrasound-Guided Biopsy in the Diagnosis of Hepatic Tumors on a Background of Advanced Chronic Liver Disease: A Prospective, Randomized, Clinical Trial.

[1]  I. Wanless,et al.  Terminology of nodular hepatocellular lesions , 1995 .

[2]  Ding‐Shinn Chen,et al.  Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma--a study based on 420 patients. , 1996, Journal of hepatology.

[3]  C. Fìlice,et al.  Is second biopsy helpful in the diagnosis of hepatocellular carcinoma with a first negative biopsy? , 2000, American Journal of Gastroenterology.

[4]  M. Bisceglia,et al.  Diagnosis of Hepatocellular Carcinoma Complicating Liver Cirrhosis: Utility of Repeat Ultrasound-Guided Biopsy after Unsuccessful First Sampling , 2002, CardioVascular and Interventional Radiology.

[5]  F. Klebl,et al.  Contrast-enhanced ultrasound allows for interventions of hepatic lesions which are invisible on convential B-mode. , 2004, Zeitschrift für Gastroenterologie - German Journal of Gastroenterology.

[6]  Wei Yang,et al.  The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy. , 2006, AJR. American journal of roentgenology.

[7]  J. Buckels,et al.  Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis , 2008, Gut.

[8]  Won Jae Lee,et al.  Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas. , 2008, AJR. American journal of roentgenology.

[9]  J. Bruix,et al.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma , 2007, Hepatology.

[10]  L. Forzenigo,et al.  The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis , 2009, Gut.

[11]  Z. Sparchez,et al.  B-mode and contrast enhanced ultrasound guided biopsy of portal vein thrombosis. Value in the diagnosis of occult hepatocellular carcinoma in liver cirrhosis. , 2010, Medical ultrasonography.

[12]  K. Lee,et al.  Real-time contrast-enhanced ultrasound-guided biopsy of focal hepatic lesions not localised on B-mode ultrasound , 2010, European Radiology.

[13]  F. Durand,et al.  Is tumor biopsy necessary? , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  Z. Sparchez,et al.  Usefulness of contrast enhanced ultrasound guidance in percutaneous biopsies of liver tumors. , 2011, Journal of gastrointestinal and liver diseases : JGLD.

[15]  G. Grazi,et al.  Pre-operative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumour grading assessment. , 2011, Journal of hepatology.

[16]  B. Goldberg,et al.  Radiological Clinical Practice Guidelines Published in the Last Decade: A Bibliometric Analysis , 2019, Journal of the Belgian Society of Radiology.

[17]  L. Solbiati,et al.  Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment , 2014, Insights into Imaging.

[18]  B. Zhai,et al.  Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results. , 2015, Ultrasound in medicine & biology.

[19]  X. Cui,et al.  EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part II – Diagnostic Ultrasound-Guided Interventional Procedures (Long Version) , 2015, Ultraschall in der Medizin.

[20]  Z. Sparchez,et al.  Prospective comparison between real time contrast enhanced and conventional ultrasound guidance in percutaneous biopsies of liver tumors. , 2015, Medical ultrasonography.

[21]  H. Seno,et al.  Sonazoid-enhanced ultrasonography guidance improves the quality of pathological diagnosis in the biopsy of focal hepatic lesions , 2016, European journal of gastroenterology & hepatology.

[22]  Jung-Hwan Yoon,et al.  Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma. , 2017, Journal of hepatology.

[23]  Ivan Bricault,et al.  EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[24]  Z. Sparchez,et al.  Contemporary role of liver biopsy in hepatocellular carcinoma , 2018, World journal of hepatology.

[25]  Francesco Paolo Russo,et al.  When and how should we perform a biopsy for HCC in patients with liver cirrhosis in 2018? A review. , 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[26]  Sang Min Lee,et al.  Clinical utility of real-time ultrasound-multimodality fusion guidance for percutaneous biopsy of focal liver lesions. , 2018, European journal of radiology.

[27]  M. Ronot,et al.  Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3 cm. , 2017, Journal of hepatology.

[28]  M. Pompili,et al.  Biopsy of Liver Target Lesions under Contrast-Enhanced Ultrasound Guidance – A Multi-Center Study , 2017, Ultraschall in der Medizin - European Journal of Ultrasound.

[29]  A. Luciani,et al.  Suspicious liver nodule in chronic liver disease: Usefulness of a second biopsy. , 2018, Diagnostic and interventional imaging.

[30]  M. Lee,et al.  A radiofrequency device for tract ablation after liver biopsy: a single-institution human feasibility study. , 2018, The British journal of radiology.

[31]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.